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Abstract
Optimal adherence to antiretroviral therapy (ART) is associated with favorable HIV outcomes, including
higher CD4 cell counts, HIV virus suppression and a lower risk of HIV transmission. However, only 25%
of people living with HIV/AIDS (PLWH) in the USA are virally suppressed. Sub-optimal adherence (<90–
95%) contributes to antiretroviral resistance and worse medical outcomes, including more rapid
progression to AIDS and death. Psychosocial factors and religion/spirituality (R/S) have a significant
impact on ART adherence, but the findings are mixed. The purpose of this study was to examine
religious and psychosocial correlates and predictors of ≥90% ART adherence in PLWH. A cross-sectional
study was conducted with a sample of 292 outpatient PLWH in the Southeastern USA. Participants
completed computerized surveys. The mean ART adherence percentage was 80.9% and only about half
reported ≥90% adherence. There were statistically significant differences in ART adherence rates based
on age, depressive symptom status and frequency of religious attendance and prayer. Praying at least
once a day was significantly associated with ≥90% ART adherence (OR = 2.26, 95% CI [1.06–4.79],
p < 0.05). Social support satisfaction was also significantly associated with ART adherence (OR = 1.52,
95% CI [1.11–2.08], p < 0.05) and energy/fatigue/vitality (OR = 1.03, 95% CI [1.00–1.05], p < 0.05).

Introduction
Optimal adherence to antiretroviral therapy (ART) is critical to achieving and sustaining favorable HIV
outcomes and HIV prevention. Lower or undetectable viral load resulting from optimal ART adherence
is linked to a lower risk of HIV transmission (Eaton et al. 2012; Nguyen et al. 2011). However, only 25%
of people living with HIV/AIDS (PLWH) in the USA are virally suppressed (Centers for Disease Control
and Prevention 2012). Insufficient or sub-optimal adherence (<90–95%) contributes to antiretroviral
resistance and worse medical outcomes, including more rapid progression to AIDS and death (Balbinet

al. 1999; Bangsberg et al. 2001; Gardner et al. 2008; Kremer et al. 2009; Mannheimer et al. 2008;
Montaner et al. 1998; Paterson et al. 2000; Stansell et al. 2001). However, improvements of even 5–
10% in adherence may lead to better biological outcomes (Bangsberg et al. 2001; Liu et al. 2006;
Paterson et al. 2000).
Although there has been major progress in HIV treatment and control, the absence of a cure and
continued spread of the virus make it a difficult chronic disease to treat. However, research indicates
that psychosocial factors, including coping, depression, social support, quality of life (QOL) factors—
particularly religion/spirituality (R/S)—have a significant impact on an HIV patient’s medical decisionmaking and treatment adherence. In previous studies, R/S has been significantly associated with better
ART adherence (Dalmida 2006; Dalmida et al. 2009; Konkle-Parker et al. 2008). However, some reports
highlight only the negative effect of R/S beliefs on medication adherence (Finocchario-Kessler et al.
2011; Wanyama et al. 2007). R/S can also dually serve as a barrier and facilitator for medication
adherence among PLWH (Kisenyi et al. 2013; Kremer et al. 2006; Tumwine et al. 2012; Vyas et al.
2014). These mixed findings regarding the role of R/S call for more research to better understand the
relationship of religious and psychosocial factors in adherence to ART. The purpose of this study was to
examine the role of religious and psychosocial factors in ART adherence rates in PLWH and to identify
predictors of greater than 90% ART adherence.

Background
Psychosocial Factors and Adherence
Decisions to adhere or not adhere to ART depend not only on patient medical characteristics, but also
on psychosocial factors, including coping, mental health, quality of life (QOL), individual beliefs about
ART, complementary/alternative medicine and spirituality (Bader et al. 2006; Kremer et al. 2006; Lyimo
et al. 2014). Coping, mental health (i.e., depression) and social support are among the most commonly
cited psychosocial predictors of ART adherence in PLWH (Bader et al. 2006; Dalmida et al. 2009;
Finocchario-Kessler et al. 2011; Fogarty et al. 2002). Depression in PLWH adversely affects adherence
to ART (Dalmida et al. 2009; Gonzalez et al. 2011a, b; Harding et al. 2010; Safren et al. 1999, 2001;
Sherr et al. 2011).
A classic review of HIV medication adherence studies (Fogarty et al. 2002) found that: (1) social and
psychological factors reflecting emotional adjustment to HIV/AIDS were related to better adherence;
(2) gender was not consistently related to adherence, no evidence of effects from CD4 count or HIV
viral load; and (3) younger age, minority status and a history of substance abuse were often related to
non-adherence (mixed effects for race/ethnicity and age). In one study of 100 PLWH (Bader et al.
2006), poorer QOL and poorer physical functioning were associated with ART discontinuation and
working and maintaining a regular daily routine were associated with better adherence. In a study of
158 PLWH (Lyimo et al. 2014), adherence was primarily predicted by negative rather than positive
coping mechanisms.

Religion/Spirituality and Health in PLWH
Religion is an important part of daily life for the majority of PLWH (85%), who often rely on R/S means
when facing problems/difficulties (72%) and self-identify as “religious” (86%) or “spiritual” (95%)
(Lorenz et al. 2005). Of the many psychosocial factors, R/S has been found to be significant sources of
stress reduction, positive coping skills and existential well-being among HIV patients (Dalmida et al.
2011; Koenig et al. 1988). In addition to being significant factors that enhance positive coping,
medication adherence and immune function, R/S is also important in the daily lives of PLWH (Dalmida
et al. 2009; Ironson et al. 2006; Kaldjian et al. 1998; Koenig 1998; Tarakeshwar et al. 2006).

Religion/Spirituality and Medical Treatment and Adherence
R/S also plays a key role in patients’ medical decisions and medical care (Bader et al. 2006; Kaldjian et
al. 1998; Parsons et al. 2006). In a study of 100 PLWH (Bader et al. 2006), “turning to spirituality” was
significantly higher in PLWH who were treatment naïve than in those who were treatment experienced
(F = 7.70 p = 0.007), in PLWH seeking or planning to seek mental health care than in those who were
not (F = 8.05 p = 0.006), and in women than in men (F = 13.65 p < 0.001). Among 306 PLWH (Parsons et
al. 2006), being in medical care was significantly related to a stronger belief that HIV is not a sin in the
eyes of God (p = 0.001). A longer lag since the last appointment kept was related to less frequent
church attendance and a poorer relationship with God (Parsons et al. 2006). The gap between
diagnosis and the start of medical care for HIV was related (p = 0.007) to a poorer relationship with
God, more education and a stronger belief that HIV is a punishment from God (Parsons et al. 2006).
The efficacy of HIV treatment is directly reliant on adherence. Patients’ decision to take or not take
their medication can be directly influenced by R/S (Bosworth 2006; Koenig and Cohen 2002; Kremer et
al. 2006). Prayer is frequently reported as a facilitator to medication adherence, and in one study its
influence was similar to or above the doctor’s recommendation to adhere (Konkle-Parker et al. 2008).
Overall, religion and various dimensions of R/S are significantly associated with ART adherence among
PLWH (Dalmida et al. 2009; Finocchario-Kessler et al. 2011; Kisenyi et al. 2013; Konkle-Parker et al.
2008; Kremer et al. 2006, 2009; Vyas et al. 2014). However, R/S has been identified as—both—a
barrier to and facilitator for medication adherence (Kisenyi et al. 2013; Tumwine et al. 2012; Vyas et al.
2014).
In a study of HIV, men and women (Kremer et al. 2009) believing that health was controlled by God or
a higher power were 4.75 times more likely to refuse ART compared to those not sharing this belief. On
the contrary, those who believed that spirituality helped them cope with the side effects of medication
reported better adherence (Kremer et al. 2009). In a longitudinal study of 350 HIV-infected adults (Vyas
et al. 2014), higher annual household income (p = 0.004) and religious affiliation (p = 0.031) were
predictive of greater medication adherence. Participants who said that their beliefs gave meaning to
their lives, made them feel they had a connection with a higher being, were influential during their
recovery, and helped them feel connected to humanity were more likely to be ≥90% adherent
(p < 0.015). Conversely, participants who believed God created all things in the universe; that God will
not turn his back on them; and those who regularly attended religious services, participated in religious

rituals, and prayed and meditated to get in touch with God were less likely to be ≥90% adherent
(p = 0.025). Similarly, in a longitudinal study of 204 PLWH (Finocchario-Kessler et al. 2011), the belief
that God is in control of one’s health was negatively associated with ≥90% ART adherence. One
prospective observational study (Wanyama et al. 2007) of 558 PLWH found that 1.2% of patients
discontinued ART because of a belief in spiritual healing and subsequently died. Studies have also
revealed both positive and negative roles of religious leaders and spiritual healers as promoters or
discouragers of ART adherence (Maman et al. 2009; Roura et al. 2010; Thielman et al. 2014; Tumwine
et al. 2012).
The purpose of this study was to examine the role of religious and psychosocial factors in ART
adherence rates in PLWH and correlates and predictors of 90% or better ART adherence. Based on
previous studies and findings, we expected that PLWH in the Southeastern USA with higher selfreported R/S and more frequent religious behavior/practices might have better ART adherence.

Methods
Participants and Procedures

A cross-sectional design was used with a non-probability sample of 292 PLWH. The sample was
recruited over a 6-month period from an outpatient infectious disease clinic at a large universityaffiliated health center and two AIDS service organizations in the Southeastern USA. Approval was
obtained from the university’s Institutional Review Board and recruitment sites prior to beginning.
Subjects were recruited using study fliers. Interested participants provided written informed consent
after a complete description of the study to the subjects by study staff. Eligibility criteria required
participants to be HIV-positive, 18 years of age or older, able to speak and understand English and
mentally competent as determined by a screening assessment with the mini mental status examination
(scores ≥ 27). The MMSE was administered by a trained research interviewer, and all other
questionnaires were administered using the Audio Computer-Assisted Self Interview (ACASI) on laptop
computers. Instrument reliabilities and scores are presented in Table 1. Each participant received $15
for participating in the study.
Table 1 . Sample characteristics
Variable
Race/ethnicity
Black
White
Age
<50 years
≥50 years
Birth sex
Female
Male
Educational level
Less than high school

n %
26390.4
18 6.2
20670.5
85 29.1
16356.2
12743.8
40 12.1

Variable
n %
High school or G.E.D.
15453.1
College or technical school
85 29.3
Grad or professional school
11 3.8
Marital status
Married
35 12.0
Divorced/separated/widowed
10636.4
Single/never married
10636.4
Committed relationship
44 15.1
Employment status
Part-time
23 8.0
Unemployed or on disability
25688.6
Annual income
<$11,000
20073.0
≥$11,000
74 25.3
Sexual orientation
Straight or heterosexual
16758.2
Gay or homosexual
54 18.8
Bisexual
26 9.1
Religious service attendance
Never or hardly (1–2 times per year) 65 24.1
1–2 times a month or so
10633.2
More than once a week
12442.8
Prayer
Never
10 3.4
Less than daily
88 30.3
Daily or more often
19266.2
Identification as religious person
Very
80 27.7
Moderately
10837.4
Slightly
56 19.4
Not at all
7 2.4
Religious affiliation
Christian/Catholic/Adventist/Methodist83 28.5
Baptist
13948.9
Jewish, Muslim or Buddhist
13 4.6
Belief in God, no affiliation
24 8.5
Atheist or no belief in God
4 1.4
ART medication adherence
<90% adherence
13646.6
≥90% adherence
10636.3

Measures
Demographic
Socio-demographic information was collected using a 20-item form developed for this study, which
asked about age, race/ethnicity, gender, year of HIV diagnosis, approximate annual and monthly
income, highest level of education completed and employment/occupational status.

Religion/Spirituality
A modified version of the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS)
(Fetzer Institute 1999) assessed religious involvement or behavior and self-rated spirituality and
religiousness. The BMMRS contains items surveying a variety of dimensions of R/S, including daily
spiritual experiences, meaning, values/beliefs, forgiveness, private religious practices, religious and
spiritual coping, religious support, R/S history, commitment, organizational religiousness, religious
preference and overall self-ranking (as a religious or spiritual person). Thirty-three of the original 38
items were administered. For the current study, only self-rated religiousness, religious affiliation and
religious behavior (religious attendance and prayer) were analyzed, based on findings from previous
research. Items about forgiveness, financial contribution to religious organizations and volunteer hours
with religious organization(s) were omitted. No reliabilities were calculated for individual items used.

Religious Coping
Religious coping was assessed using brief religious coping scale (RCOPE) (Pargament et al. 1998), which
has 14 items that measure positive religious coping and negative religious coping, with 7 items each
(Pargament et al. 1998). Participants rate their use of individual coping strategies when dealing with
difficult life situations using a 4-point rating scale from (1) “not at all” to (4) “a great deal.” Positive
religious coping items include strategies such as seeking spiritual support and benevolent reappraisals.
The negative religious coping scale contains items related to spiritual struggle such as, “I questioned
God’s love for me” and “I wondered whether God had abandoned me.” Responses are summed to
create subscale scores, with higher scores representing more frequent use of negative or positive
religious coping.

Perceived Stress
Stress was assessed using the Perceived Stress Scale (PSS) (Cohen et al. 1983), which consists of 10
items designed to tap the degree to which respondents found their lives unpredictable, uncontrollable
and overloaded. This scale has been reliably used in populations of PLWH.

Depressive Symptoms
The Center for Epidemiological Studies Depression scale (CES-D) was used to assess symptoms of
depression over the previous 7 days (Radloff and Locke 1986). The scale consists of 20 items, each of

which is scored on a 4-point frequency scale from (0) “rarely” to (3) “most or all” of the time. Radloff
(1977) established that CES-D scores of 16 or above indicated a significant level of depression. The CESD scale reliability has been established and used successfully in PLWH (Miles et al. 1997; Vedhara et al.
1999).

Social Support
Satisfaction with social support was assessed using the Social Support Questionnaire–6 (SSQ-6)
(Sarason et al. 1987), a six-item, abbreviated version of the 27-item Social Support Questionnaire. The
items assess the number of available people that the individual feels he or she can turn to and the
individual’s degree of satisfaction with the perceived support available on a 6-point Likert scale, from 1
for “very dissatisfied” to 6 for “very satisfied.” The SSQ-6 has high internal reliability, with alphas from
0.90 to 0.93. Cronbach’s alpha in this study was 0.94.

HIV Medication Adherence
The Antiretroviral General Adherence Survey (AGAS) (Holstad et al. 2006; Holstad et al. 2010) was used
to measure adherence to HIV medications. The AGAS is comprised of 5 items that focus on the ease
and ability of taking HIV medications as prescribed. Responses are reported on a 6-point Likert scale
with responses ranging from 1 (none of the time) to 6 (all of the time). Four items focus on the
perceived ability to take ART as the healthcare provider recommended, and one item asks participants
to rate how often, in general, they were able to take the medications as recommended in the previous
30 days. Total scores range from 5 to 30, with higher scores indicating higher levels of adherence. Raw
scores can be described as a proportion by dividing the score by the total possible (i.e., a raw score of
27 translates into 90% adherence) (Holstad et al. 2010). The proportion score can be used to assess the
overall level of adherence in the 30-day period. We also used a dummy-coded adherence score for
some analyses: 0 = <90% adherence or AGAS score of <27; 1 = ≥90% adherence (or AGAS score of ≥27).

Quality of Life
Health-related quality of life (HRQOL) was measured using the RAND-36-Item Health Survey 1.0 (Hays
et al. 1993), which assesses HRQOL in eight dimensions and includes physical functioning, role
limitations due to physical health, role limitations due to emotional or personal problems, vitality
(energy/fatigue), general health, emotional well-being, social functioning and bodily pain experienced
during the previous 4 weeks (Hays et al. 1993). Subscale response sets vary between scales. For
example, for the physical functioning scale, responses occur on a 3-point scale that include (1) “yes,
limited a lot,” (2) “yes, limited a little,” or (3) “no, not limited at all” in response to a list of daily
activities such as walking, bending, vacuuming or engaging in sports. The emotional well-being scale
responses are on a 6-point scale ranging from, (1) “all of the time” to (6) “none of the time.” Items are
recoded per a scoring key provided by RAND researchers where a high score denotes a more favorable
state of health with a range of 0–100 (from lowest to highest).

Statistical Analyses
Data were analyzed using the IBM® SPSS 22.0 statistical software package. Descriptive statistics were
used to describe the sample. Histograms, box-plots and Shapiro–Wilk normality test were used to
examine normality of the data. Only age, years living with HIV and the energy/fatigue HRQOL subscale
were normally distributed; therefore, Spearman’s rho bivariate correlations were used to examine the
bivariate associations between adherence and covariates. 5% significance levels were used unless
otherwise indicated. For some analyses, we dichotomized age (<50 and ≥50 years old) based on widely
accepted national guidelines from the Centers for Disease Control and Prevention (Castro et al. 1993),
which consider HIV-infected individuals aged 50 years and older as older adults. Chi-square tests were
used to examine associations between categorical variables and percent ART adherence. One-way
analysis of variance (ANOVA) was used to examine differences in mean adherence percentages by
socio-demographic, depressive symptom status and religious factors. The F-statistic and p value were
used to indicate significant differences in the reported means.
Logistic regression analyses examined the ability of religious coping scores to distinguish between
participants that adhered to ART ≥90% versus those who adhered to ART <90%. The dummy coded,
binary ART adherence variable was the dependent variable. A 3-block stepwise logistic regression
model was conducted using the backward method. Significant socio-demographic covariates were
entered together in the first step, significant psychosocial and physical variables in the second step,
and significant religious variables were entered in the last step. Collinearity statistics, including a
tolerance of less than 0.20 or 0.10 and/or a variance inflation factor (VIF) of 5 or 10 and above, were
used to indicate a multicollinearity problem (O’brien 2007). None of the independent variables
included in the regression model indicated multicollinearity. For each model, the omnibus tests (Chisquare statistic and p value < 0.005), percentage of correct estimation and Nagelkerke R-square
statistic for each block provided an evaluation of the overall significance of the models and various
statistics, including beta coefficients, standard error of the betas, Wald Chi-square, odds ratio
(exponentiated beta) and confidence interval, provided evaluation of the significance (p value < 0.05)
of each independent variable. The Hosmer and Lemeshow goodness-of-fit test provided an estimate of
how well the model fit the data.

Results
Sample Characteristics
Sample characteristics are presented in Table 1. The final sample included 292 predominantly AfricanAmerican PLWH who resided in the Southeastern USA. Blacks made up 90% of the sample. More than
half of the participants were female (56%), had attained a high school diploma or GED (53%) and selfidentified as heterosexual (58%). Majority (73%) of the participants were either
divorced/separated/widowed (36%) or single/never married (36%). The sample was largely
economically disadvantaged and impoverished. The majority of participants were unemployed or on
disability (89%) and earned less than $11,000 annually (73%). More than three quarters of the
participants attended religious services fairly regularly with almost half attending more than once per
week (42.8%) and one-third reported attending at least one or twice per month (33%). Most of them

prayed daily or more often (66%) and a small proportion (3.4%) reported never praying. Most
identified themselves as moderately or very religious (65%) and 2% were not religious at all. The
sample was predominantly Christian, from a range of denominations—the largest was Baptist (49%).
Almost half of participants reported less than 90% proportion of taking medications as prescribed
within the previous 30 days (47%). The average adherence rate was 81% (SD = .19; not shown in table).
Bivariate Correlation Results: Correlates of 90% or Better ART Adherence
The descriptive characteristics of the psychosocial, religious and demographic factors assessed and
their correlations with the dichotomous ART adherence variable (0 = <90%, 1 = ≥90% adherence) are
presented in Table 2. Average age of participants was 45.1 years (SD 7.75), and they had been living
with HIV for 10.8 years (SD 6.96) on average. Prayer (daily or more often), religious attendance (weekly
or more often) and higher social support satisfaction, physical role limitations, emotional role
limitations, physical function, energy/vitality, emotional well-being and social functioning scores were
significantly correlated with ≥90% adherence. Conversely, higher depressive symptoms, perceived
stress and negative religious coping scores were significantly correlated with <90% adherence.
Table 2. Instrument scores and correlates of greater than 90% ART adherence
Descriptive

Correlates of ≥90% ART
Medication adherencea
n Mean SD Min Max Alpha r
pvalue
HIV medication adherence23924.3 5.87 5 30 0.78 –
–
Depressive symptoms
27519.3 12.840 57 0.91 −.32
.000
Positive religious coping 29116.6 5.06 0 21 0.92 0.12
.061
Negative religious coping 2914.9 5.34 0 21 0.86 −.29
.000
Social support satisfaction 28830.5 8.15 5 36 0.91 0.29
.000
Physical role limitations 28947.9 41.910 100 0.86 0.13
.048
Physical function
29058.7 28.590 100 0.9 0.16
.013
Emotional role limitations 28952.4 44.2 0 100 0.86 0.24
.000
Energy/vitality
28953.1 21.6 0 100 0.68 0.26
.000
Emotional well-being
28962.4 23.838 100 0.82 0.36
.000
Social functioning
28967.0 29.380 100 0.55 0.28
.000
Pain
28960.4 29.890 100 0.85 0.12
.059
Perceived stress
29017.9 7.65 0 38 0.86 −.35
.000
Years diagnosed with HIV 28110.8 6.96 0 35 –
−.08
.249
Age (continuous)
29145.1 7.75 19 67 –
.03
.676
Age (0 = <50, 1 = ≥50)
291–
–
– – –
.10
.112
b
290–
–
– – –
−.06
.396
Gender
281–
–
– – –
.01
.928
Racec
d
274–
–
– – –
.09
.159
Income
e
291–
–
– – –
.07
.317
Marital status
f
290
–
–
–
–
–
.10
.132
Education
g
247–
–
– – –
−.06
.380
Sexual orientation
h
263–
–
– – –
−.12
.076
Religious affiliation

Descriptive

Correlates of ≥90% ART
Medication adherencea
n Mean SD Min Max Alpha r
pvalue
i
242–
–
– – –
.18
.005
Prayer
j
241–
–
– – –
.16
.001
Religious attendance
Bold values indicate statistical significance (p < 0.05)
aART adherence proportion within previous 30 days: 0 = <90%, 1 = ≥90%
bGender: 0 = female, 1 = male
cRace: 0 = non-Black, 1 = Black
dAnnual income: 0 = < $21,000, 1 = ≥ 21,000
eMarital status: 0 = separated, widowed, divorced, never married,1 = married or in a committed relationship
fEducation: 0 = less than high school, 1 = high school or greater
gSexual orientation: 0 = heterosexual or straight, 1 = gay or bisexual
hReligious affiliation: 0 = atheist/no belief in God, 1 = Christian, 2 = other
iPrayer: 0 = less than daily, 1 = daily or several times daily
jReligious attendance: 0 = less than weekly, 1 = weekly or more

Results of Chi-Square Tests of Association

The results of the Chi-square test for the associations between ART adherence and the various
psychosocial, religious and demographic factors assessed are presented in Table 3. All the variables
assessed were statistically significant at p < 0.05, except for age. Compared to PLWH who reported
<90% adherence, a higher proportion of PLWH who reported ≥90% adherence, reported no symptoms
of depression, prayed daily or more often, attended religious services weekly or more often, reported
having a life-changing religious experience and experienced a significant gain in their faith and no loss
in faith. Conversely, among those who reported depressive symptoms (n = 137), 69% were <90%
adherent vs. 31% who reported ≥90% adherence (Χ 2 (1) = 18.6, p < .01), indicating that those who
PLWH who were depressed were more likely to less adherent. Similarly, among those who prayed less
than daily (n = 83), 69% were non-adherent versus 31% who were adherent (Χ 2 (1) = 8.0, p = .01).
PLWH who attended religious services less than weekly tended to be significantly more likely to report
<90% adherence (64%) than ≥90% adherence (37%).
Table 3. Association between ART adherence and psychosocial, religious and demographic factors
Variables

n

<90% adherence

≥90% adherence

136

106

n (%)

n (%)

Age
<50 years

166

99 (59.6)

67 (40.4)

≥50 years

76

37 (48.7)

39 (51.3)

Chi-square
(df)

pvalue

5.72 (1)

.111

Variables

n

<90% adherence

≥90% adherence

136

106

n (%)

n (%)

Depressive
symptoms
Non-depressed

103

42 (40.8)

61 (59.2)

Depressed

137

94 (68.6)

43 (31.4)

Prayer
<daily

83

57 (68.7)

26 (31.3)

≥daily

159

79 (49.7)

80 (52.9)

Religious attendance
<weekly

137

87 (63.5)

50 (36.5)

≥weekly

104

49 (47.1)

55 (52.9)

Life-changing
religious experience
No

57

39 (68.4)

18 (31.6)

Yes

182

97 (53.3)

85 (46.7)

Significant gain in
faith
No

46

35 (76.1)

11 (23.9)

Yes

193

100 (51.8)

93 (48.2)

Significant loss in
faith
No

160

83 (51.9)

77 (48.1)

Yes

79

52 (65.8)

27 (34.2)

Chi-square
(df)

pvalue

18.55 (1)

.000

7.99 (1)

.005

6.46 (1)

.011

4.05 (1)

.044

8.91 (1)

.003

4.19 (1)

.041

Bold values indicate statistical significance (p < 0.05)

Mean Differences in ART Adherence Rates

ANOVA results (Table 4) showed that average ART adherence rates differed significantly between
participants based on age, depressive symptoms status, religious attendance and prayer. That is, there

were significantly higher mean ART adherence percentages among PLWH who: (a) were ≥50 years
compared to <50 years (M = 0.85 vs 0.79); (b) were not depressed compared to those depressed
(M = 0.87 vs. 0.76); (c) attended religious services at least once a week compared to those who
attended less than once a week (M = 0.84 vs. 0.78); and (d) who prayed at least once a day compared
to less than once a day (M = 0.83 vs. 0.77).
Table 4. Mean differences in ART adherence rates by age, depressive symptoms and religious factors
Variable

N

%

% ART adherence
Mean

SD

Age
<50 years

206

70.5

.79

.20

≥50 years

85

29.1

.85

.17

Depressive symptoms
Non-depressed

164

56.2

.87

.17

Depressed

125

42.8

.76

.20

Religious attendance
<weekly

166

56.8

.78

.21

≥weekly

124

42.5

.84

.18

Prayer
<daily

98

33.6

.77

.20

≥daily

192

65.8

.83

.19

F

Sig.

5.861

.016

17.61

.000

5.901

.016

5.791

.017

Bold values indicate statistical significance (p < 0.05)

Logistic Regression Results: Predictors of 90% or Better ART Adherence
The results of the 3-block stepwise logistic regression analysis predicting 90% or greater ART adherence
from socio-demographic, psychosocial and physical variables in addition to religious variables are
presented in Table 5. Assessment of goodness of fit using the Hosmer–Lemeshow (H–L) test produced
insignificant results (p > .05) in all the three models, indicating that the models fit the data well. All
overall model blocks, except model/block 1, were statistically significant as indicated by overall Chisquare statistics for each block that were significant at 1% level. The final model (block 3) predicted
63.6% of the responses correctly and the Nagelkerke R2 was .309, indicating that the predictors
accounted for approximately 30.9% of the variance in adherence.

Table 5. Summary of logistic regression analysis for variables predicting ≥90% ART medication adherence rates
Independent variable

B

SE
(B)

Block 1 (demographic factors)

χ2

df

Sig.

3.281

2

.194

Odds
ratio

95% CI for Exp
(B)

eβ

Lower

Upper

Agea

.597

.347

2.964

1

.085

1.817

.921

3.586

Years diagnosed with HIV

−.035

.024

2.131

1

.144

.965

.920

1.012

3.281

2

.194

Goodness-of-fit test: Hosmer
and Lemeshow

15.472

8

.051

Block 2 (psychosocial factors)

46.410

9

.000

Overall χ 2
Nagelkerke R2 = .020
% correct (≥90%
adherence) = 31.3

Social support satisfaction

.419

.160

6.875

1

.009

1.521

1.112

2.081

Physical function

−.003

.008

.143

1

.706

.997

.981

1.013

Role limitations due to
physical problems

−.001

.006

.016

1

.899

.999

.988

1.010

Role limitations due to
emotional problems

.001

.005

.050

1

.824

1.001

.991

1.012

Energy/fatigue/vitality

.027

.012

4.889

1

.027

1.028

1.003

1.053

Social functioning

.000

.008

.000

1

.998

1.000

.984

1.017

Pain

−.006

.007

.690

1

.406

.994

.980

1.008

Perceived stress

−.061

.036

2.904

1

.088

.941

.877

1.009

Depression

.015

.022

.424

1

.515

1.015

.971

1.060

49.691

11

.000

Overall χ 2
Nagelkerke R 2 = .272

Independent variable

B

SE
(B)

χ2

df

Sig.

Odds
ratio

95% CI for Exp
(B)

eβ

Lower

Upper

% correct (≥90%
adherence) = 65.7
Goodness-of-fit test: Hosmer
and Lemeshow

8.270

8

.408

Block 3 (religious factors)

7.907

4

.095

Negative religious coping

−.035

.036

.950

1

.330

.966

.900

1.036

Prayerb

.813

.385

4.471

1

.034

2.255

1.061

4.793

Positive religious coping

−.058

.039

2.222

1

.136

.943

.873

1.019

Religious attendancec

.417

.367

1.289

1

.256

1.517

.739

3.117

57.597

15

.000

5.992

8

.648

% correct (≥90%
adherence) = 63.6
Overall χ 2
Nagelkerke R 2 = .309
Goodness-of-fit test: Hosmer
and Lemeshow

Bold values indicate statistical significance (p < 0.05)
e B or Exp (B) = exponentiated B, equivalent to the odds ratio. B, SE(B), eβare from the final block in the full
model
aAge group: 0 = < 50 years, 1 ≥ 50 years
bPrayer: 0 = less than daily, 1 = daily or several times daily
cReligious attendance: 0 = less than weekly, 1 = weekly or more
After controlling for all the variables, prayer was the only religious variable that significantly predicted
adherence. Whereby, compared to those who prayed less than daily, PLWH who prayed at least once daily were
2.26 times more likely to adhere to ART medications ≥90% of the time (95% CI [1.06–4.79], p < 0.05).
Additionally, higher social support satisfaction (OR = 1.52, 95% CI [1.11–2.08], p < 0.05) and
energy/fatigue/vitality (OR = 1.03, 95% CI [1.00–1.05], p < 0.05) scores were significantly associated with ≥90%
ART adherence.

Discussion
This study was designed to examine the ability of religious coping scores to predict ART medication
adherence, taking into consideration select demographic and psychosocial factors in a sample
predominantly composed of Black, economically disadvantaged and impoverished PLWH. Results
showed that more than three quarters of the participants attended religious services fairly regularly.
The mean ART adherence rate was 81%, with almost half of the participants reporting less than 90%
adherence. These rates are consistent with previous studies showing moderate to low ART adherence
among HIV-infected adults (Fogarty et al. 2002; Hinkin et al. 2004). ANOVA analysis indicated that
there were statistically significant differences in mean ART adherence rates based on age, depressive
symptom status, religious attendance and prayer. These findings are similar to previous studies that
found that average ART adherence scores differed by age such that PLWH who are 50 years or older
report better adherence (Fogarty et al. 2002; Hinkin et al. 2004). Additionally, the results regarding
differences in ART adherence rates based on depressive symptom status are consistent with the
findings from previous studies regarding the deleterious effects of depressive symptoms on ART
adherence in PLWH (Dalmida et al. 2009; Gonzalez et al. 2011a, b; Harding et al. 2010; Safren et al.
1999, 2001; Sherr et al. 2011).
No known studies have compared ART adherence rates or percentages based on frequency of religious
attendance or prayer. Nonetheless, previous studies have also identified prayer as a facilitator to
medication adherence (Konkle-Parker et al. 2008). However, a study by Vyas et al. 2014 found that
those who regularly attended religious services and “prayed and meditated to get in touch with God”
were less likely to be ≥90% adherent. Our study found the exact opposite, supported by Chi-square
tests and partially supported by logistic regression.
Logistic regression analyses showed that praying at least once a day was significantly associated with
≥90% ART adherence (2.2 times more likely). Greater satisfaction with social support was also
significantly associated with ≥90% adherence such that PLWH who were most satisfied with their social
support were 1.5 times more likely to report adhering to their ART 90% or better within the previous
30 days. Comprehensive reviews have also identified the positive role of social support in ART
adherence (Fogarty et al. 2002), and previous studies have identified positive associations between
social support satisfaction and ART adherence scores (Dalmida et al. 2009). This is one of the first
studies to identify the role of vitality in ART adherence in PLWH. Results showed that PLWH in the
sample who reported greater vitality were one time more likely to adhere to their ART at least 90% of
the time. This is also one of the first known studies to identify the role of life-changing religious
experiences and gains or losses in faith in ART adherence among PLWH. Unlike some previous studies
(Vyas et al. 2014), this study did not identify income or religious affiliation as significant correlates or
predictors of ART adherence.
Some of this study’s notable limitations include the cross-sectional design which prevents the ability to
make causal inferences and the limited generalizability to similar PLWH. Additionally, the study was
conducted in the Southeastern region of the USA—the “Bible Belt” and majority of the participants
were African-American and impoverished; therefore, findings may only be generalizable to similar

PLWH and those in this region or similar. This study did not examine the relationship between ART
adherence and R/S factors related to meaning and purpose in life, which have previously been
associated with ≥90% ART adherence (Vyas et al. 2014).
In spite of the limitations and mixed findings regarding the dual role of religious and spiritual factors in
ART adherence, this study: (a) confirms findings from previous studies, (b) challenges/confronts
findings from other studies and (c) offers new findings regarding the role of vitality, life-changing
religious experiences and gains or losses in faith in better understanding ART adherence. Some of the
differences in findings may be due to how variables such as “regular” religious attendance or frequency
of prayer were defined or coded and whether meditation was combined into one variable along with
prayer. Additionally, it is important to note that this study included a fairly homogenous sample of
predominantly African-American, impoverish, PLWH in the Southeastern USA. Some of the previous
studies including Vyas et al. (2015) included samples of PLWH on the West Coast USA (California),
which may have different R/S beliefs and experiences from the “Bible Belt” region of the USA. It is also
important to note that religious beliefs, interpretations, experiences and behaviors are not identical,
even within religious traditions, and do not form a coherent system that permeate all aspects of
people’s lives (Chaves 2010). These incongruences may affect individuals’ general and health-related
decision-making behavior and may help explain some of the variations in findings between samples
and studies.

Conclusions
This study showed that about half of PLWH still struggle to achieve optimal ART adherence and are
therefore in need of support. ART adherence rates vary among PLWH and may be based on age,
depressive symptom status and religious behavior, including frequency of religious attendance and
prayer. Additionally, prayer, energy/vitality and social support are significant predictors of ART
adherence. These factors should, therefore, be assessed and considered in the treatment plan as
healthcare providers collaborate with patients and other members of the care team, including mental
health providers, social workers and chaplains or pastoral counselors.
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